Macrotech Developers is viewed positively by brokerages as they evaluate its performance in revenue, collections, and strategic land acquisitions.
Nomura: Buy | Target Price: ₹1,600 | Upside: 45%
Nomura maintains a Buy rating on Macrotech Developers with a target price of ₹1,600, implying a substantial 45% upside. The brokerage anticipates strong second-half FY25 growth driven by pre-sales, operating cash flow, and revenue recognition. Nomura also highlights Macrotech’s shift to premiumization in the Palava project and its expansion into new regions like Bangalore.
Morgan Stanley: Equal-weight | Target Price: ₹1,230 | Upside: 11%
Morgan Stanley has an Equal-weight rating on Macrotech with a target price of ₹1,230. The firm notes steady pre-sales and collections growth, with EBITDA margins holding at 27% quarter-over-quarter. While revenue and EBITDA showed a sequential decline, Macrotech’s focus on digital infrastructure and expansion in Chennai is seen as a positive long-term growth strategy.
Nomura is optimistic about Macrotech’s expansion and premiumization strategy, while Morgan Stanley takes a more balanced view, highlighting steady margins but advising caution due to recent sequential declines in revenue and EBITDA.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investors should perform due diligence before making investment decisions.
